PathoQuest, a life sciences spin-out of the Pasteur Institute and the Ecole Nationale Vétérinaire d’Alfort (ENVA), has raised €3.8m ($5m) in series B private equity (PE) funding.
Participants in the round were PE firms IDInvest Partners, Kurma Life Science Partners, and Aurinvest.
The funding will be used to fuel Paris-based PathoQuest’s trials and technology development. The firm is working on next-generation infectious disease diagnostic arrays, which it plans to launch in 2015.
Japan's sophisticated network of university investment funds make it an outlier among other Asian countries.
The universities of Durham, Newcastle, Northumbria, Sunderland and Teesside are the latest group of academic institutions in the UK to launch a fund to invest in their spinouts.
While universities often push their academics to be more entrepreneurial, having a professor lead a spinout decreases its chances of raising money and being acquired, according to research by Harvard associate professor Maria Roche.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
